Speaker illustration

Professor Hui-Nam Pak

Yonsei University, Seoul (Korea (Republic of))

Professor of Medicine, Director of Cardiac Intrervention & Electrophysiology Laboratory Division of Cardiology, Yonsei University Health System Scientific Program Chair, Asian Pacific Heart Rhythm Society, 2017-Present. Director of Policy and Insurance, Korean Heart Rhythm Society, 2017-Present. Allied Professional Subcommittee Chair, Asian Pacific Heart Rhythm Society, 2016-2017. International Cooperation Subcommittee Chair, Korean Heart Rhythm Society, 2016-2017. Scientific Program Chair, Korean Heart Rhythm Society, 2013-2016. Outside Cooperation Committee Chair, Severance Cardiovascular Hospital, 2017-Present. Director of Arrhythmia Center, Severance Cardiovascular Hospital, 2016-Present. Director of Cardiac Intervention and Electrophysiology Laboratory, Severance Cardiovascular Hospital, 2014-Present. Director of Electrophysiology Laboratory, Severance Cardiovascular Hospital, 2009-2014.

Machine learning and computer modeling the future of AF ablation.

Event: EHRA 2022

Topic: Rhythm Control, Catheter Ablation

Session: The future of atrial fibrillation (AF) ablation around the world

Thumbnail

Electrical posterior box isolation in persistent atrial fibrillation changed to paroxysmal atrial fibrillation: a multi-center, prospective, randomized study

Event: ESC Congress 2020

Topic: Rhythm Control, Catheter Ablation

Session: Ablation for Atrial Fibrillation around the Globe; Techniques, Technologies and More

Thumbnail

Approach to mapping and ablation of focal atrial tachycardia

Event: EHRA 2019

Topic: Treatment

Session: State of the Art review of paroxysmal supraventricular tachycardia from a clinician's point of view

Thumbnail

Poor rhythm outcome of catheter ablation for early onset atrial fibrillation in women: mechanistic insight

Event: EHRA 2018

Topic: Rhythm Control, Catheter Ablation

Session: Atrial fibrillation ablation - How to product success

Thumbnail

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb